Form 4: AVITA Medical Director McNamara Reports Acquisition of Shares and Stock Options

Director Robert McNamara reports acquisition of AVITA Medical shares and stock options.

Summary

• Robert McNamara, a director of AVITA Medical, Inc., reported a transaction on June 5, 2024.
• McNamara acquired 9,200 shares of common stock and 3,943 stock options.
• The stock options have an exercise price of $9.51 and expire between June 5, 2025, and June 5, 2034.
• The acquired shares are Restricted Stock Units (RSUs) that vest 12 months following the grant date.
• Following the transaction, McNamara beneficially owns 25,749 shares of common stock, including unvested RSUs, and 3,943 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a director suggests confidence, but it's a routine filing.

Positives

• The acquisition of shares and stock options by a director could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company directors and officers.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates